Bcl-XL inhibits p53- but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line

International Journal of Cancer

Volumn 109, Issue 1, 2004, Pages 38-42

  Schoop, Remilio A L ^a,b   Kooistra, Klaas ^b   Baatenburg De Jong, Robert J ^a   Noteborn, Mathieu H M ^a,b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Leadd BV   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Apoptin; Apoptosis; Bcl XL; Caspase 3; Cytochrome c; p53; Squamous cell carcinoma of head and neck

Indexed keywords

APOPTIN; CASPASE 3; CYTOCHROME C; PLASMID DNA; PROTEIN BCL XL; PROTEIN P53; ANTINEOPLASTIC AGENT; BCL2L1 PROTEIN, HUMAN; CAPSID PROTEIN; CASP3 PROTEIN, HUMAN; CASPASE; PROTEIN BCL 2; PROTEIN BCL X; VP3 PROTEIN, CHICKEN ANEMIA VIRUS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL FRACTIONATION; GENETIC TRANSFECTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; BIOSYNTHESIS; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; HEAD AND NECK TUMOR; METABOLISM; MITOCHONDRION; MUTATION; PROGNOSIS; TIME; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CAPSID PROTEINS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; MUTATION; PLASMIDS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUBCELLULAR FRACTIONS; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0742305156     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11675     Document Type: Article

References (29)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-804.
3. Shah JP, Lydiatt W. Treatment of cancer of the head and neck. CA Cancer J Clin 1995;45:352-68.
4. Gastman BR. Apoptosis and its clinical impact. Head Neck 2001;23:409-25.
5. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2:594-604.
6. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000;157:1415-30.
7. Pena JC, Thompson CB, Recant W, Vokes EE, Rudin CM. Bcl-XL and Bcl-2 expression in squamous cell carcinoma of the head and neck. Cancer 1999;85:164-70.
8. Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov 2002;1:111-21.
9. Ohnishi K, Ora I, Takahashi A, Yane K, Matsumoto H, Ohnishi T. Transfection of mutant p53 gene depresses X-ray- or CDDP-induced apoptosis in a human squamous cell carcinoma of the head and neck. Apoptosis 2002;7:367-72.
10. Noutomi T, Chiba H, Itoh M, Toyota H, Mizuguchi J. Bcl-X(L) confers multi-drug resistance in several squamous cell carcinoma cell lines. Oral Oncol 2002;38:41-8.
11. Zhan Q, Alamo I, Yu K, Boise LH, Cherney B, Tosato G, O'Connor PM, Fornace AJ Jr. The apoptosis-associated gamma-ray response of BCL-X(L) depends on normal p53 function. Oncogene 1996;13:2287-93.
12. Minn AJ, Rudin CM, Boise LH, Thompson CB. Expression of Bcl-XL can confer a multidrug resistance phenotype. Blood 1995;86:1903-10.
13. Fernandez Y, Espana L, Manas S, Fabra A, Sierra A. Bcl-XL promotes metastasis of breast cancer cells by induction of cytokines resistance. Cell Death Differ 2000;7:350-9.
14. Zhuang SM, Shvarts A, van Ormondt H, Jochemsen AG, van der Eb AJ, Noteborn MHM. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res 1995;55:486-9.
15. Danen-van Oorschot AAAM, den Hollander AI, Takayama S, Reed JC, van der Eb AJ, Noteborn MHM. BAG-1 inhibits p53-induced but not apoptin-induced apoptosis. Apoptosis 1997;2:395-402.
16. Danen-van Oorschot AAAM, Fischer DF, Grimbergen JM, Klein B, Zhuang S, Falkenburg JH, Backendorf C, Quax PH, van der Eb AJ, Noteborn MHM. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci USA 1997;94:5843-7.
17. Danen-van Oorschot AAAM, van der Eb AJ, Noteborn MHM. The chicken anemia virus-derived protein apoptin requires activation of caspases for induction of apoptosis in human tumor cells. J Virol 2000;74:7072-8.
18. Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res 2000;6:1563-73.
19. Noteborn MHM, Todd D, Verschueren CA, de Gauw HW, Curran WL, Veldkamp S, Douglas AJ, McNulty MS, van der Eb AJ, Koch G. A single chicken anemia virus protein induces apoptosis. J Virol 1994;68:346-51.
20. Zha J, Harada H, Osipov K, Jockel J, Waksman G, Korsmeyer SJ. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J Biol Chem 1997;272:24101-4.
21. Juin P, Hueber AO, Littlewood T, Evan G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev 1999;13:1367-81.
22. Danen-van Oorschot AAAM. A viral protein that induces tumor-specific apoptosis. Thesis. Leiden, The Netherlands: Leiden University, 2001.
23. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996;87:619-28.
24. Schmitz JC, Liu J, Lin X, Chen TM, Yan W, Tai N, Gollerkeri A, Chu E. Translational regulation as a novel mechanism for the development of cellular drug resistance. Cancer Metastasis Rev 2001;20:33-41.
25. Kirsch DG, Kastan MB. Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol 1998;16:3158-68.
26. Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope 2002; 112:638-44.
27. Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T, Yuan J. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-XL. Nat Cell Biol 2001;3:173-82.
28. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513-9.
29. Yang SE, Hsieh MT, Tsai TH, Hsu SL. Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. Biochem Pharmacol 2002;63:1641-51.